Study of the synthesis, catabolism and nature of y-globulin has been facilitated by the availability in mice of transplantable plasma-cell tumors, each capable of synthesizing characteristic and different forms of plasma globulin (1). Since the use of such tumors in inbred mice readily permits multiple comparable observations, a study was carried out in sufficient detail to permit evaluation of the effects of different plasma-cell tumors on the metabolism of individual serum proteins. The findings were compared with those in human multiple myeloma in which published results are few and apparently conflicting. Thus, Berson and Yalow (2) found the fractional turnover rate of a y-myeloma protein to be approximately normal in the donor patient as well as in another patient without a serum myeloma protein. Lippincott and coworkers (3, 4), however, observed a rapid turnover of normal y-globulins and -y-myeloma proteins in patients with -y-myeloma proteins. Gammaglobulin turnover was less rapid in patients with ,8-myeloma proteins. Neufeld (5) also noted a rapid turnover for globulins in a patient with a y-myeloma protein.
Study of the synthesis, catabolism and nature of y-globulin has been facilitated by the availability in mice of transplantable plasma-cell tumors, each capable of synthesizing characteristic and different forms of plasma globulin (1) . Since the use of such tumors in inbred mice readily permits multiple comparable observations, a study was carried out in sufficient detail to permit evaluation of the effects of different plasma-cell tumors on the metabolism of individual serum proteins. The findings were compared with those in human multiple myeloma in which published results are few and apparently conflicting. Thus, Berson and Yalow (2) found the fractional turnover rate of a y-myeloma protein to be approximately normal in the donor patient as well as in another patient without a serum myeloma protein. Lippincott and co- workers (3, 4) , however, observed a rapid turnover of normal y-globulins and -y-myeloma proteins in patients with -y-myeloma proteins. Gammaglobulin turnover was less rapid in patients with ,8-myeloma proteins. Neufeld (5) also noted a rapid turnover for globulins in a patient with a y-myeloma protein.
Two tumors were selected for the present study. The plasma-cell tumor 5563 (6) produces a y-myeloma protein that is a y-globulin on immunoelectrophoresis and a single 6.5S component on ultracentrifugal analysis. This is analagous to the y-type myeloma proteins in man. A second mouse plasma-cell tumor, 5647 (7), however, produces a 8-myeloma protein with ultracentrifugal components of 9, 11 and 13S and distinctive immunological properties similar to the characteristic features of beta (ft2A)-type myeloma globulins in man. The serum levels of the normal y-globuilin components are reduced with the 5563 tumor, lbut this is less evident with the 5647 tumor. * Presenit address: National Cancer Institute, Bethesda, Md. Purified albumin, normal y-globulin, and 5563 y-myeloma protein from the mouse and normal human 6.6S y-globulin were labeled with radioiodine. The metabolic behavior of these proteins was studied in normal mice as well as in mice bearing the y (5563) plassma-cell tumor, the 8 (5647) plasmia-cell tumor or a mamimary carcinoma. This last tumor producel no serum myeloma protein l)ut was transplanted and grew in the same way as did the others and thus served as a control for the effect of the presence of neoplasm per se on the turnover of these proteins.
The y (5563) plasm-ia-cell tumor has a profound effect, markedly increasing the turnover of both normal mouse y-globulin and 5563 y-myeloma globulin. Less Figure 1 .
Each plasma-cell tumor produces a characteristic protein: the 5563 tumor forms a large amount of y-myeloma protein, while the 5647 tumor forms large amounts of f-myeloma globulin. The physicochemical and immunochemical properties of these myeloma proteins are described in detail elsewhere (8, 9) . The mammary carcinoma was not associated with any significant clhanges 1696 in plasma proteins wMien exallince(l lby paper electrol)lioresis ( Figure 1 ).
Proteinis. Normal mouse 'v-globulin was prepared from the pooled serum of normal adult CH mice or from pooled peritoneal fluid obtained from mice which had been hyperimmunized with hemocyanin (Maia squinado) in Freund's adjuvant (10, 11) . Zone electrophoresis was carried out on polyvinyl chloride particle blocks (Geon 426) (12) , and serial fractions from the 'y-globulin region of each block were individually tested for the presence of 'y-globulin and other serum proteins by the Ouchterlony technique (agar double-diffusion) employing potent rabbit antisera against normal mouse serum proteins and against normal mouse 'y-globulin (9) . Those 'y-globulin fractions which were free from contaminating protein were pooled and concentrated by ultrafiltration (13), dialyzed against pH 7.4 sodium phosphate-buffered saline and tested for purity by starch gel electrophoresis and immunoelectrophoresis employing rabbit antinormal mouse serum. At no time in the preparation of the normal mouse 'y-globulin or the 5563 myeloma protein were the fractions frozen.
The 5563 myeloma protein was prepared by the method of Askonas (14) (12) , with all initial concentration of 0.015 M phosphate in a pH 6.5 potassium buffer and a limit concentration of 0.050 M phosphate while retaining pH 6.5. The central portion of the myeloma protein elution peak was pooled, concentrated, dialyzed and tested in the same manner as the normal serum '-globulin.
Mouse albumin was prepared from normal C3H mouse serum by Geon block electrophoresis, and selection of the midportion of the albumin zone for concentration and dialysis against buffered saline as described above. The final preparation contained small amounts of a prealbumin and a postalbumin component when tested by starch gel electrophoresis.
Human 'v-globulin was prepared by DEAE-cellulose chromatography of serum from a normal adult male donor. A gradient elution system, starting with a 0.01 M phosphate, pH 8 buffer, permitted separation of an initial fraction containing only 6.6S 'y-globulins (12) .
No other fractionation procedure (i.e., ethanol) was employed. The starch gel electrophoretic properties of the serum protein fractions are shown in Figure 2 .
Iodiiuation with I". Iodination was performed by the iodine monochloride method of McFarlane (16) (26, 27) . NMS = normal mouse serum, NMy = normal mouse 'y-globulin, 5563 MP = myeloma protein from sera of mice bearing the 5563 plasma-cell tumor, NMA = normal mouse albumin, NH-y = normal human 6.6S y-globulin, NHS = normal human serum.
acid. Counting was continued long enough to give an accuracy of at least ± 3 per cent. All figures were corrected for radioactive decay.
Blood samples during the experiments were taken from the retro-orbital venous plexus under ether anesthesia by a technique similar to that described by Halpern and Pacaud (18) . At the end of the experiment the mice were sacrificed and bled out from the heart with a heparinized syringe. The terminal blood samples were used for determination of the hematocrit values. The mice were then weighed (allowance being made for the blood removed) and tumors were excised and weighed separately.
Methods of calculation. Blood volumes were calculated from the radioactivity of blood samples taken 2 to 3 minutes after injection of known amounts of radioactive protein into a tail vein. Plasma volumes were obtained from a knowledge of the blood volumes and the hematocrit values. The ratio of the extravascular to the intravascular plasma protein pools was calculated from the decay curve of plasma protein radioactivity as indicated by Wasserman and Mayerson (19) . Approximately 15 gc (1.5 mg) of each material to be examined was injected into the tail veins of 4 or more mice. The findings within each group agreed closely except when there was a gross difference in tumor sizes. For this reason mean values are recorded, unless there was a reason for recording values individually for each mouse in a group. The half-time was determined from graphic plots of the total body radioactivity corrected for physical decay.
The per cent P'31-protein degraded per day was obtained by dividing the observed half-time into 0.693, the natural logarithm of one-half. The quantity of any protein in the circulation (total circulating component), the total amount of exchangeable component, and the quantity of the protein component degraded per day were calculated in the usual way (17) .
RESULTS

Turnover in normal mice
Mouse albumin. Approximately 15 ,uc (1.5 mg) 1131-mouse Albumin obtained from C3H mice was injected into four normal C3H mice weighing 21 to 29 g (mean 27 g). The findings in respect to disappearance of radioactivity from the whole body are illustrated in Figure 3 where labeled albumin was found to have a mean half-life of 1.54 days. Since the plasma radioactivty was 98 to 99 per cent protein-bound at all times in the experiment, the whole-body radioactivity curves can be taken to represent J131-protein catabolism. Normal y-globulin. J'31-labeled normal C;H mouse y-globulins were administered to a total of eight normal C3H mice in two separate experiments and were found to have a mean half-time of 4.6 days, as shown in Figure 3 . The same halftime was observed when y-globulin was given to normal BAlb/c mice. In order to check that the half-life of the various proteins obtained by wholebody radioactivity was close to their half-life in the plasma, blood samples were examined daily in several tests. Figure 4 shows that the elimination rate for normal mouse -y-globulin agreed well with that observed by whole-body counting. The mean value for the half-life of normal mouse y-globulin observed here is considerably longer than previously reported values (20) . Reasons for this are considered in the Discussion. 5563 Myeloma protein. The 5563 y-myeloma protein was treated by the normal mouse in the same manner as normal mouse y-globulin. When injected into eight normal mice the mean was found to be 4.9 days (Figure 3 ). There was no difference in the behavior of 5563 myeloma protein when given to normal CQH or BAlb/c mice.
Normal human y-globulin. Approximately 1.5 mg of I131 human 6.6S y-globulin was injected intravenously into five normal C3H mice. Since no antibody formed during the first 5 days, it was possible to measure the elimination rate with reasonable accuracy before immune elimination occurred. Only whole-body counts were made in this experiment. It is evident from Figure 3 that normal mice treat human y-globulin and mouse -y-globulin in a similar way, both having a half-life of 4.6 days. normal mice. Even a 1.2 g tumor, which represented less than 5 per cent of the total body weight, had a profound effect on y-globulin turnover ( Figure 5 ). The turnover of 5563 y-myeloma protein was also markedly increased by the tumor. A mean half-time of 1.5 days was observed in four mice bearing tumors with an average weight of 3.3 g. The half-life of the various proteins obtained by whole-body counting was checked by measurement of their half-life in the plasma. The data in Figure 4 , showing the elimination of I'31-labeled normal mouse y-globulin, or 5563 myeloma protein (two in each group of four normal mice and four mice with 5563 plasma-cell tumor), correlate well with the elimination rates determined by wholebody counting.
Albumin turnover," by contrast, was not appreciably altered in four mice bearing 5563 tumors weighing 3.7 to 6.9 g (mean 4.9). As is shown in Figure 7 , the half-time was 1.46 days.
Human y-globulin turnover was also measured in four mice with 5563 tumors, as is shown in Figure 8 , and was found to be accelerated (mean half-time 2.8 days) in mice with tumors weighing 3.7 to 6.9 g. This effect, although real, is less marked than that seen with the homologous globulins.
5647 Plasma-cell tumor. This /8-globulin-producing tumor had less effect on y-globulin turnover than did the y-type plasma-cell tumor (Fig- Human y-globulin turnover was also less markedly affected, the mean half-time being 4.1 days for seven mice with 5647 tumors (Figure 8) Figure 5 , the turnover of llmouse y-globulin was normal, the mean halftime being 4.8 days in four mice with a mean tumor weight of 3.3 g. Albumin turnover was slightly prolonged, with a mean half-time of 1.9 days in four mice whose tumors weighed 2 to 7 g (mean 5; Figure 7 ).
Rates of protein synthesis
The intravascular pool of serum protein, determined from the measurements given in Figure  4 . constituted about 45 per cent of the total in the body. In Table I Presence of the 5563 plasma-cell tumor more than doubled the fractional rate of normal y-globulin removal. Calculation of the rate of normal t Values based on estimations described in the text.
I % Pa3-lprotein degraded per day = 100 (1 -0.693) y-globulin synthesis in the presence of this tumor, however, requires an assumption as to the level of the normal y-globulin components. The large amount of myeloma protein overshadows much of the y-globulin region and prevents quantitative measurement of the normal components, but immunoelectrophoresis and starch gel electrophoresis have shown that normal -y-globulin components are reduced (8, 9) . Since such analyses were not susceptible to quantitative assessment, two sets of calculations are made in Table II , based on the assumption that normal y-globulin concentrations were in the range of one-half to one-quarter the normal level. If these assumptions are correct, the rate of y-globulin synthesis was about normal in the presence of the 5563 tumor.
The ft-globulin-producing 5647 plasma-cell tumor had much less effect on the fractional rate of y-globulin removal than the y-globulin-producing 5563 tumor, although the mean tumor weights were approximately the same: 3.2 and 3.4 g, respectively.1 Difficulties in measuring the level of 1 The calculations of the catabolism of normal mouse -y-globulin in the mice bearing the 5647 tumor are based on the turnover of y-myeloma protein administered to these mice. Because of the similarity of normal -y-globulin and 5563 -y-myeloma protein metabolism in normal and 5563 tumor-bearing mice, it seems reasonable to believe that this will apply also for mice with the 5647 tumor. normal y-globulins were encountered also with the 5647 tumor, but qualitative tests indicated that the y-globulins were not so markedly reduced with this tumor and, therefore, calculations were made, assuming normal or half-normal y-globulin levels. Gamma-globulin synthesis, as shown in Table II , appeared to be normal in the presence of this tumor.
Gamma-globulin levels were slightly elevated by the presence of the mammary carcinoma, perhaps because some of the tumors were partially necrotic. The fractional rate of y-globulin removal was normal with these tumors (Table II) , although the rate of y-globulin synthesis appeared to be increased.
The 5563 myeloma protein was very rapidly degraded in the presence of the 5563 tumor, almost half of the protein being removed and replaced per day. The rate of 5563 myeloma globulin synthesis was calculated to be approximately 19 mg protein per g tumor per day.
DISCUSSION
The catabolic behavior of y-globulin differed notably from that of albumin in the mouse. The half-life of 4.6 and 1.5 days for these two proteins differs considerably and, in this feature, stands apart from the usual finding in species other than 170)2 rodents (20) . The mean half-life of 4.6 days for normal mouse y-globulin is longer than the 1.9 lays previously reported (20) . The reason for this may be that the materials which we used were prepared and iodinated by techniques that more effectively avoided denaturation, or that the y-globulin used in previous reports contained other serum globulins, since uncontaminated y-globulins are difficult to obtain from mouse serum. In this connection it is worth noting that the y-globulins tested in the present study had antibody activity and were isolated by preparative electrophoresis with care, in order to obtain only uncontaminated y-globulin fractions. The y-globulins were not frozen after purification, and iodination was carried out with a molecular ratio for iodine: y-globulin of 1: 2 or less.
The factors controlling catabolism of normal y-globulins and other serum proteins are unknown. Campbell and co-workers (17) (20) y-globulin to mouse y-globulins, their half-life in mice being almost the same. Whatever the factors that determine their catabolic rate, it is apparent that there are some relevant differences between mouse and human y-globulin molecules, since the presence of the 5563 plasma-cell tumor caused a greater increase in the rate of turnover of the one than of the other.
In view of the evidence that myeloma proteins in both mouse and man can be classified into two major groups, the y-type and 8 (or 82A)-type myeloma proteins (8) , and because of the physicochemical and immunochemical differences between these groups, a comparison of the metabolic blehavior of rel)resentative proteins from these two groups would be important. (24) . Askonas (14) , however, has shown that 5563 tumor slices form protein at a slower rate in vitroi.e., 1.5 to 2 mg per g tumor per day, approximately one-tenth the in vivo rate.
Synthesis of 5563 myeloma protein occurs as rapidly in the plasmna-cell tumor as does synthesis of albumin in mouse liver, which also forms approximately 19 mg albumin per g tissue each day.
Low serum albumin levels, a common feature of malignant disease in nman, were found in the animals bearing the tumors used in the present study. Steinfeld (25) studied the turnover of albumin in 12 patients with neoplastic disease and found that the percentages of body albumin degra(le(l and synthesized per day were abnormal except in the one patient with multiple myeloma. Neufeld (5) reported a normal half-time for albumin in two patients with myeloma. Similarly in mice, the mammary carcinoma depressed the percentage of albumin ldegraded and synthesized per day, although the 5563 mouse plasma-cell tumnor did not have this effect. Speculation on the sionih1canice of a difference between the effects of carcinomatous and plasma-cell malignancies on albumin metabolism, however, should await further study.
SUMMARY
Transplantable plasma-cell tumors in mice closely resemble multiple myeloma in man, and both result in decreased serum levels of normal y-coml)onents and of albumin, in the presence of large amounts of myeloma protein.
The metabolism of normal mouse y-globulin, of a mouse y-myeloma protein, of normal human y-globulin, and of mouse albumin was studied in normal mice or tumor-bearing mice by means of purified proteins labeled with I131.
The tumors were a y-type (5563) plasma-cell tumor, a /3-type (5647) plasma-cell tumor, and a mammary carcinoma with similar growth characteristics.
In normal mice the half-time for the turnover of all three y-globtulins was 4.6 days, while the half-time for albiumini was 1.54 (lays.
The y-tN pe l)lasiiia-cell tumor caused a very marked acceleration of y-globulin catabolism, while the /3-type tumor had much less, and the mammary carcinomna no such effect. Neither in normal nor in tumior-bearing mice was there any difference between the behavior of y-myelomia globulin and of normal y-globulin.
In normal mice about 20 times more albumin than normal y-globulin was synthesized each day. The synthesis of normal y-globulin and of albumin was unaltered by the presence of the plasma-cell tumor.
The 5563 plasma-cell tumor synthesized about 19 mg of myeloma protein per g wet weight per day. This rate is at least as great as that of albumin synthesis in the liver.
